1,8-naphthalimide-based DNA intercalators and anticancer agents: a systematic review.

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• Drug Discovery

Background:

• 1,8-Naphthalimide derivatives are recognized for their DNA-intercalating properties and anticancer potential.
• Mechanisms include Topoisomerase I/II inhibition and photoinduced DNA cleavage, leading to potent cytotoxicity.

Purpose of the Study:

• To provide a comprehensive overview of recent advances in the design and biological evaluation of 1,8-naphthalimide-based DNA intercalators.
• To systematically categorize these compounds and discuss their structure-activity relationships, cytotoxic profiles, and mechanisms of action.

Main Methods:

• Literature review focusing on recent publications in anticancer drug development.
• Systematic categorization of 1,8-naphthalimide derivatives into distinct structural classes.
• Analysis of structure-activity relationships, cytotoxicity data, and mechanistic studies.

Main Results:

• Overview of various classes: mono-intercalators, fused-ring-extended analogs, photoactive agents, bifunctional conjugates, and organometallic hybrids.
• Detailed discussion of structure-activity relationships and cytotoxic profiles for each class.
• Insights into diverse mechanisms contributing to anticancer efficacy.

Conclusions:

• 1,8-Naphthalimide derivatives represent a versatile scaffold for anticancer drug development.
• Integrated perspective across multiple structural classes highlights their translational potential.
• Guidance for future rational design of naphthalimide-based therapeutics is provided.